Detalles de la búsqueda
1.
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.
Br J Haematol
; 177(4): 601-611, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28474336
2.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(4): 698-704, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785332
3.
Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.
Stem Cells
; 33(6): 1807-17, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25640200
4.
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL.
Br J Haematol
; 171(5): 763-75, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471982
5.
A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation.
Biol Blood Marrow Transplant
; 20(8): 1229-37, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769329
6.
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
Cytotherapy
; 16(10): 1431-40, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24856896
7.
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
Pediatr Blood Cancer
; 61(7): 1289-94, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24623601
8.
Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated with Significantly Decreased 1-Year Survival.
Transplant Cell Ther
; 30(1): 103.e1-103.e8, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806447
9.
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial.
Front Neurol
; 15: 1263373, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841694
10.
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
Biol Blood Marrow Transplant
; 18(2): 324-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22079471
11.
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality.
Br J Haematol
; 156(1): 99-108, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22008222
12.
T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients.
Br J Haematol
; 157(2): 205-19, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22313507
13.
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial.
J Immunother Cancer
; 10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584865
14.
Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant.
Bone Marrow Transplant
; 57(4): 586-592, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110690
15.
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.
Front Immunol
; 13: 1055497, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36569951
16.
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.
Br J Haematol
; 155(2): 218-34, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21848882
17.
Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
Cytotherapy
; 13(6): 730-8, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21413839
18.
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
Bone Marrow Transplant
; 56(9): 2221-2230, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33958740
19.
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL.
Oncotarget
; 11(32): 3035-3047, 2020 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32850008
20.
Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Biol Blood Marrow Transplant
; 15(12): 1587-95, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19896083